Leukaemia Foundation
Services offered
Chemotherapy is the main treatment for younger people with acute myeloid leukaemia (AML).
It’s normally given in two phases. Both phases use a high dose of chemotherapy drugs, so you will usually need to stay in hospital for several weeks each time.
Common side effects include an increased risk of infection, nausea, hair loss and tiredness.
Chemotherapy uses drugs to kill leukaemia cells or slow their growth. Treatment protocols set out which drugs to have, how much and how often. You can find information about protocols at eviQ, although your haematologist may need to tailor the drugs to your individual situation. For AML, there are usually 2 phases of high-dose chemotherapy. Chemotherapy drugs are most commonly given as a liquid through a drip inserted into a vein (intravenous infusion). Some drugs can be given as tablets you swallow.
For more information, see Managing side effects and Chemotherapy.
As well as killing leukaemia cells, the drugs may also damage healthy fast-growing cells, such as new blood cells or the cells in the mouth, stomach, hair and bowel. This can cause side effects such as hair loss, high risk of infection, mouth sores, body aches, nausea, vomiting, constipation or diarrhoea, skin and nail changes, memory and concentration problems, and tiredness (fatigue).
Chemotherapy for AML is usually given in 2 phases: induction and consolidation.
Leukaemia Foundation
Services offered
Find the right services for your needs, wherever you are in Australia
Trusted cancer information for all people affected by cancer
We're available 9am - 5pm, Monday to Friday (excluding public holidays)